Mereo BioPharma Group plc - ADR (MREO) has risen Monday morning, with the stock rising 32.56% in pre-market trading to 1.71.
MREO's short-term technical score of 69 indicates that the stock has traded more bullishly over the last month than 69% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, Mereo BioPharma Group plc - ADR ranks higher than 86% of stocks.
Mereo BioPharma Group plc - ADR has fallen 17.31% over the past month, closing at $1.46 on September 18. During this period of time, the stock fell as low as $1.19 and as high as $1.68. MREO has an average analyst recommendation of Strong Buy. The company has an average price target of $4.33.
MREO has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on MREO!
Mereo BioPharma Group plc - ADR has a Long-Term Technical rank of 81. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 19% of the market scoring higher. In the Biotechnology industry which is number 137 by this metric, MREO ranks better than 137% of stocks.
